The DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.
Caregiver Perspectives About Using Antipsychotics and Other Medications for Symptoms of Dementia
Abstract
Background and Objectives: To avoid "chemical restraints," policies and guidelines have been implemented to curb the use of medications for behavioral and psychological symptoms of dementia (BPSD). Antipsychotics have been particularly targeted because of their rare severe side effects. Consequently, caregiver directed non-pharmacologic therapies have increased while medication use for BPSD has diminished. Despite such initiatives, however, antipsychotics continue to be prescribed "off-label" for roughly 20% of nursing home patients. How caregivers impact management approaches and prescribing decisions for BPSD, including antipsychotic use, is poorly understood. Aim: assesses experiences and perceptions of family and nursing caregivers regarding factors influencing medication decisions for BPSD. Research Design and Methods: Semi-structured interviews, analyzed via template, immersion and crystallization, and thematic development. Thirty-two participants from Northwestern Virginia representing five groups of caregivers for dementia patients were interviewed: families of community-dwelling, assisted living, and nursing home patients, and nurses from the same assisted living/nursing home facilities. Results: Caregivers described three major themes regarding medications: (a) Systemic barriers exist for non-pharmacologic BPSD therapies. (b) Medications have few barriers, and seem generally effective and safe. (c) When non-pharmacologic measures fail, medications, including antipsychotics, may be necessary and appropriate for palliation of patient distress. Discussion and Implications: To further reduce medications for BPSD, obstacles to services and alternative therapies must be mitigated. Caregiver perceptions that medications are generally safe and effective contribute to their continued use. Guidelines and policies for BPSD management should incorporate the caregiver position that medications, including antipsychotics, are sometimes justified and required to alleviate patient suffering.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In seven studies, psychotropic medication was used to manage behaviours and BPSD [49, 53, 57, 63, 65, 80, 81].”
From Stakeholders' views on the use of psychotropic medication in older people: a systematic review (2022) · cites this paper as [65]
In the citing paper
“However, family caregivers had a differing view to other stakeholders in this area and did not always feel that their concerns were listened to by healthcare professionals [51, 65].”
From Stakeholders' views on the use of psychotropic medication in older people: a systematic review (2022) · cites this paper as [65]
In the citing paper
“Doctors and nurses were of the view that assessing whether psychotropic medication was appropriate in older people was challenging [49, 53–56, 62, 65, 80–82].”
From Stakeholders' views on the use of psychotropic medication in older people: a systematic review (2022) · cites this paper as [65]
In the citing paper
“Many doctors referred to the process of a risk–benefit analysis [53–56, 59, 65, 82].”
From Stakeholders' views on the use of psychotropic medication in older people: a systematic review (2022) · cites this paper as [65]
In the citing paper
“However, side effects associated with psychotropic medication were also minimised by some older people, doctors and family members [54–56, 59, 63, 65, 74, 81, 82].”
From Stakeholders' views on the use of psychotropic medication in older people: a systematic review (2022) · cites this paper as [65]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Ryan, G. W., & Bernard, H. R. (2003) · Field Methods · doi:10.1177/1525822x02239569 · Cited by 5,475 · cited 1×
“Because we had “rich narratives” from “verbatim textual data,” two authors (JWK, JDW) employed Ryan and Bernard’s method of metaphor and allegory to further delineate and evaluate patterns and potentially significant “themes and subthemes” (Ryan & Bernard, 2003).”
MethodSample size in qualitative research
Sandelowski, M. (1995) · Research in Nursing & Health · doi:10.1002/nur.4770180211 · Cited by 4,372 · cited 1×
“Maximal variation strategy was employed to find community families who did and did not attend senior activities outside of the home, and in diverse locations, employing private physician offices and senior care facilities to aid in recruitment (Sandelowski, 1995).”
(1999) · Practitioner Research in Counselling · doi:10.4135/9781849209588.n8 · Cited by 3,958
Qualitative Data Analysis for Health Services Research: Developing Taxonomy, Themes, and Theory
Bradley, E. H., Curry, L. A., & Devers, K. J. (2007) · Health Services Research · doi:10.1111/j.1475-6773.2006.00684.x · Cited by 3,437
By the American Geriatrics Society 2015 Beers Criteria Update Expert Panel (2015) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13702 · Cited by 2,609
The American Geriatrics Society 2012 Beers Criteria Update Expert Panel (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2012.03923.x · Cited by 2,578
Lyketsos, C. G., Lopez, O., Jones, B., Fitzpatrick, A. L., Breitner, J., & DeKosky, S. (2002) · JAMA · doi:10.1001/jama.288.12.1475 · Cited by 2,049
Schneider, L. S., Dagerman, K. S., & Insel, P. (2005) · JAMA · doi:10.1001/jama.294.15.1934 · Cited by 1,671 · cited 4×
“3% taking antipsychotics), may be hard to distinguish in the milieu of chronic illness (Ray, Chung, Murray, Hall, & Stein, 2009; Schneider et al., 2005).”
BackgroundInfluentialAtypical antipsychotic drugs and the risk of sudden cardiac death
Ray, W. A., Chung, C. P., Murray, K. T., Hall, K., & Stein, C. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0806994 · Cited by 1,194
Crabtree, B. F., Miller, W. L., & Swenson, M. M. (1995) · Nursing Research · doi:10.1097/00006199-199507000-00011 · Cited by 956
Pharmacological Treatment of Neuropsychiatric Symptoms of Dementia: A Review of the Evidence
Sink, K. M., Holden, K. F., & Yaffe, K. (2005) · JAMA · doi:10.1001/jama.293.5.596 · Cited by 910
Brod, M., Stewart, A. L., Sands, L., & Walton, P. (1999) · The Gerontologist · doi:10.1093/geront/39.1.25 · Cited by 672
Effect of Citalopram on Agitation in Alzheimer Disease: The CitAD Randomized Clinical Trial
Porsteinsson, A. P., Drye, L. T., Pollock, B. G., Devanand, D. P., Frangakis, C., Ismail, Z., Marano, C., Meinert, C. L., Mintzer, J. E., Munro, C. A., et al. (2014) · JAMA · doi:10.1001/jama.2014.93 · Cited by 572 · cited 3×
“Citalopram has been shown to significantly reduce agitation, but its use is limited by concerns about adverse cognitive and cardiac effects (Porsteinsson et al., 2014).”
BackgroundInfluentialMaher, A. R., Maglione, M., Bagley, S., Suttorp, M., Hu, J.-H., Ewing, B., Wang, Z., Timmer, M., Sultzer, D., & Shekelle, P. G. (2011) · JAMA · doi:10.1001/jama.2011.1360 · Cited by 558 · cited 2×
“Of medications, antipsychotics have the best evidence for management of agitated and psychotic symptoms in dementia, though the reported benefit is modest: between one in four and one in three patients show improvement (Maher et al., 2011; Sink et al., 2005).”
BackgroundKochanek, K. D., Murphy, S. L., Xu, J., & Tejada‐Vera, B. (2016) · PubMed · Cited by 520
Nonpharmacologic Management of Behavioral Symptoms in Dementia
Gitlin, L. N., Kales, H. C., & Lyketsos, C. G. (2012) · JAMA · doi:10.1001/jama.2012.36918 · Cited by 495 · cited 1×
“…targeted behaviors, reduce caregiver fatigue, improve patient and caregiver quality of life, and delay institutionalization (Fleiner, Leucht, Forstl, Zijlstra, & Haussermann, 2017; Gitlin et al., 2012; Gitlin, Winter, Dennis, Hodgson, & Hauck, 2010; Lorusso & Bosch, 2017; Zhang et al., 2017).”
Shared decision making about screening and chemoprevention
Sheridan, S. L., Harris, R. P., & Woolf, S. H. (2004) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2003.09.011 · Cited by 441
Reus, V. I., Fochtmann, L. J., Eyler, A. E., Hilty, D. M., Horvitz-Lennon, M., Jibson, M. D., Lopez, O. L., Mahoney, J., Pasic, J., Tan, Z. S., et al. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.173501 · Cited by 441
Toot, S., Swinson, T., Devine, M., Challis, D., & Orrell, M. (2017) · International Psychogeriatrics · doi:10.1017/s1041610216001654 · Cited by 421
Gitlin, L. N., Winter, L., Dennis, M. P., Hodgson, N., & Hauck, W. W. (2010) · JAMA · doi:10.1001/jama.2010.1253 · Cited by 367 · cited 1×
“Interventions employing “navigators” or “coordinators” of care have also been found to improve outcomes for families, and would seem to fill most needs described here by caregivers (Brodaty & Gresham, 1989; Gitlin et al., 2010).”
BackgroundHearing Their Voice: A Systematic Review of Dementia Family Caregivers’ Needs
McCabe, M., You, E., & Tatangelo, G. (2016) · The Gerontologist · doi:10.1093/geront/gnw078 · Cited by 300
Zhang, Y., Cai, J., An, L., Hui, F., Ren, T., Ma, H., & Zhao, Q. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2016.12.003 · Cited by 276
Effect of a training programme to reduce stress in carers of patients with dementia.
Brodaty, H., & Gresham, M. (1989) · BMJ · doi:10.1136/bmj.299.6712.1375 · Cited by 259 · cited 1×
“Interventions employing “navigators” or “coordinators” of care have also been found to improve outcomes for families, and would seem to fill most needs described here by caregivers (Brodaty & Gresham, 1989; Gitlin et al., 2010).”
BackgroundCarey, J. W., Morgan, M., & Oxtoby, M. J. (1996) · CAM Journal · doi:10.1177/1525822x960080030101 · Cited by 258
Evaluating the Quality of Life of Long-Term Care Residents With Dementia
Sloane, P. D., Zimmerman, S., Williams, C. S., Reed, P. S., Gill, K. S., & Preisser, J. S. (2005) · The Gerontologist · doi:10.1093/geront/45.suppl_1.37 · Cited by 171
Practice‐Based Evidence and Qualitative Inquiry
Leeman, J., & Sandelowski, M. (2012) · Journal of Nursing Scholarship · doi:10.1111/j.1547-5069.2012.01449.x · Cited by 120
Quantity and Quality of Life: Duties of Care in Life-Limiting Illness
Gawande, A. A. (2016) · JAMA · doi:10.1001/jama.2015.19206 · Cited by 116 · cited 1×
“Although attending to the wishes of those terminally ill should drive the efforts of caregivers, current data about of their quality of life show that those efforts all too often fall significantly short of that goal (Gawande, 2016).”
BackgroundMontgomery, K. (2019) · Cited by 101
Algar-Skaife, K., Woods, B. T., & Windle, G. (2014) · Dementia · doi:10.1177/1471301214540163 · Cited by 87
Cornegé‐Blokland, E., Kleijer, B. C., Hertogh, C. M. P. M., & van Marum, R. J. (2010) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2010.10.004 · Cited by 87
Buckley, T., Fauth, E. B., Morrison, A. S., Tschanz, J. T., Rabins, P. V., Piercy, K. W., Norton, M. C., & Lyketsos, C. G. (2012) · International Psychogeriatrics · doi:10.1017/s1041610212000063 · Cited by 75 · cited 1×
“…it is often these behavioral and psychological symptoms which most adversely affect patient and caregiver quality of life, costs of care, independence, and institutionalization (Buckley et al., 2012; Lyketsos et al., 2002; Toot, Swinson, Devine, Challis, & Orrell, 2017; Tschanz et al., 2005).”
BackgroundA Model to Describe the Relationship Between Knowledge, Skill, and Judgment in Nursing Practice
Evans, R., & Donnelly, G. W. (2006) · Nursing Forum · doi:10.1111/j.1744-6198.2006.00053.x · Cited by 74 · cited 1×
“Personal perspectives derived from experience caring for patients, rather than guidelines and statistics alone, can drive much of medical decision making for physicians and nurses (Evans & Donnelly, 2006; Groopman, 2007).”
BackgroundBerry, S. D., Placide, S. G., Mostofsky, E., Zhang, Y., Lipsitz, L. A., Mittleman, M. A., & Kiel, D. P. (2015) · The Journals of Gerontology Series A · doi:10.1093/gerona/glv091 · Cited by 60 · cited 1×
“Further, both antidepressants and benzodiazepines have been shown to cause more falls in nursing home patients than antipsychotics (Berry et al., 2016; Wei, Simoni-Wastila, Lucas, & Brandt, 2016).”
BackgroundLorusso, L. N., & Bosch, S. J. (2016) · The Gerontologist · doi:10.1093/geront/gnw168 · Cited by 59
Woolf, S. H., Krist, A. H., Johnson, R. E., & Stenborg, P. S. (2004) · Patient Education and Counseling · doi:10.1016/j.pec.2003.12.002 · Cited by 54
Bonner, A., Field, T. S., Lemay, C. A., Mazor, K. M., Andersen, D. A., Compher, C., Tjia, J., & Gurwitz, J. H. (2015) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13230 · Cited by 52 · cited 4×
“Similar to previous studies, the greatest congruence between families and nurses occurred in symptoms warranting medications when non-pharmacologic measures failed (Bonner et al., 2015; Cornege-Blokland et al., 2012).”
BackgroundResultInfluentialCMS Seeks to Reduce Antipsychotic Use in Nursing Home Residents With Dementia
Mitka, M. (2012) · JAMA · doi:10.1001/jama.2012.7422 · Cited by 47 · cited 2×
“” Soon renamed the “National Partnership to Improve Dementia Care,” it had the clear goal of reducing inappropriate prescribing of antipsychotics in nursing homes (Mitka, 2012; “Press Releases: Senators Blumenthal, Kohl, Grassley Seek to Protect The Elderly And Taxpayers From Abusive Overprescribing Of Antipsychotics,…”
BackgroundLapeyre‐Mestre, M. (2016) · Drugs & Aging · doi:10.1007/s40266-016-0414-x · Cited by 47 · cited 2×
“Expert consensus recommends against chronic benzodiazepine use in the patient with dementia due to a diversity of risks, though they are still prescribed for BPSD (de Souto Barreto, Lapeyre-Mestre, Cestac, Vellas, & Rolland, 2016; Lapeyre-Mestre, 2016; Sink et al., 2005).”
BackgroundFleiner, T., Leucht, S., Förstl, H., Zijlstra, W., & Häussermann, P. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160683 · Cited by 47
Wei, Y. J., Simoni, J. M., Lucas, J. A., & Brandt, N. (2016) · The Journals of Gerontology Series A · doi:10.1093/gerona/glw095 · Cited by 39
Tschanz, J. T., Treiber, K., Norton, M. C., Welsh-Bohmer, K. A., Toone, L., Zandi, P. P., Szekely, C. A., Lyketsos, C. G., Breitner, J. C. S., & The Cache County Study Group (2005) · Care management journals · doi:10.1891/cmaj.6.2.107 · Cited by 35
Forester, B. P., Vanelli, M., Hyde, J., Perez, R. J. G., Ahokpossi, C., Sribney, W. M., & Adkison, L. E. (2007) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2007.09.001 · Cited by 31 · cited 1×
“Mood stabilizers have little proven benefit, are often sedating, and can cause severe side effects, some highlighted by FDA boxed warnings (Forester et al., 2007; Sink et al., 2005).”
BackgroundBarreto, P. D. S., Lapeyre‐Mestre, M., Cestac, P., Vellas, B. J., & Rolland, Y. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12847 · Cited by 28
The Use of Cognitive Enhancers in Behavioral Disturbances of Alzheimer's Disease
Miller, L. J. (2007) · The Consultant Pharmacist · doi:10.4140/tcp.n.2007.754 · Cited by 25 · cited 1×
“The benefit of cognitive enhancers for psychiatric symptoms is small but statistically significant (Miller, 2007).”
BackgroundAndrade, C., & Radhakrishnan, R. (2009) · PubMed Central · Cited by 13
Fitzsimmons, S., Barba, B., & Stump, M. (2014) · Journal of Gerontological Nursing · doi:10.3928/00989134-20141215-01 · Cited by 12 · cited 1×
“Some BPSD respond well to these methods, whereas others, such as hallucinations, are not as amenable to non-pharmacologic techniques (Fitzsimmons et al., 2015; Gitlin et al., 2012).”
BackgroundCorrelates of Caregiver Participation in a Brief, Community-Based Dementia Care Management Program
Mavandadi, S., Patel, S., Benson, A., DiFilippo, S. D., Streim, J. E., & Oslin, D. W. (2016) · The Gerontologist · doi:10.1093/geront/gnw127 · Cited by 10 · cited 1×
“Unfortunately, uptake of these types of supports in controlled studies is often disappointing (Mavandadi et al., 2016).”
BackgroundAtypical Antipsychotic Drugs, Dementia, and Risk of Death
Sikand, H., Jaojoco, J., Linares, L., & Phillips, P. S. (2006) · JAMA · doi:10.1001/jama.295.5.495-a · Cited by 7
Cited by
Roberti, J. E., Cummings, A. J., Myall, M., Harvey, J. M., Lippiett, K. A., Hunt, K. J., Cicora, F., Alonso, J. P., & May, C. R. (2018) · BMJ Open · doi:10.1136/bmjopen-2018-023507 · Cited by 181
Ongoing Medical Management to Maximize Health and Well-being for Persons Living With Dementia
Austrom, M. G., Boustani, M. A., & LaMantia, M. A. (2017) · The Gerontologist · doi:10.1093/geront/gnx147 · Cited by 62
Assessment of Patient-Preferred Language to Achieve Goal-Aligned Deprescribing in Older Adults
Green, A. R., Aschmann, H. E., Boyd, C. M., & Schoenborn, N. L. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.2633 · Cited by 61
Green, A. R., Lee, P. J., Reeve, E., Wolff, J. L., Chen, C. C. G., Kruzan, R. M., & Boyd, C. M. (2019) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2019.03.180335 · Cited by 55
“For example, 1 recent qualitative study of caregivers suggests that they believe antipsychotic medications to treat behavioral and psychological symptoms of dementia are generally safe, despite their well-documented potential for severe side effects.(37) However, other qualitative studies reveal that older adults and…”
BackgroundGreen, A. R., Boyd, C. M., Gleason, K. S., Wright, L., Kraus, C. R., Bedoy, R., Sanchez, B., Norton, J. D., Sheehan, O. C., Wolff, J. L., et al. (2020) · Journal of General Internal Medicine · doi:10.1007/s11606-020-06063-y · Cited by 52
“This finding has been affirmed by previous studies,(27) in which caregivers expressed that they were “on their own” in managing behavioral symptoms of dementia.(28) As a result, the OptiMize tip sheets incorporated the following suggestions for clinicians: “Listen first—the patient and their family and friends are the…”
Result
Metadata
- Authors
- Kerns, J. W., Winter, J. D., Winter, K. M., Kerns, C. C., & Etz, R. S.
- Affiliations
- Virginia Commonwealth University (US)
- Corresponding author
- Kerns, John William
- Venue
- The Gerontologist
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-04-11
- Volume
- 58
- Issue
- 2
- Pages
- e35-e45
- ISSN
- 0016-9013 (ISSN-L)
- 1758-5341
- OpenAlex
- W2606293935
- Cited by
- 62
- References
- 49
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 11 · 2023: 8 · 2022: 14 · 2021: 4 · 2020: 7 · 2019: 4 · 2018: 3 · 2017: 4
- FWCI
- 4.04
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Gerontologist (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Geriatrics and Gerontology › Geriatric Care and Nursing Homes
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Keywords
- dementia, behavioral and psychological symptoms of dementia, antipsychotic drugs, off-label drug use, nursing homes, family caregivers, non-pharmacological treatment, medication decision-making, caregiver perceptions, chemical restraint, assisted living
- MeSH terms
- Clinical Decision-Making, Aged, Attitude to Health, Behavioral Symptoms, Dementia, Female, Homes for the Aged, Humans, Male, Nursing Homes, Antipsychotic Agents, United States, Caregivers, Risk Assessment, Qualitative Research, Inappropriate Prescribing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.